Drug Shortage Report for TEVA-CEPHALEXIN 250

Last updated on 2020-01-30 History
Report ID 103578
Drug Identification Number 00342092
Brand name TEVA-CEPHALEXIN 250
Common or Proper name CEPHALEXIN 250MG FOS
Company Name TEVA CANADA LIMITED
Active Ingredient(s) CEPHALEXIN
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 100ML
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-15
Estimated end date 2020-02-29
Actual end date 2020-01-29
Shortage status Resolved
Updated date 2020-01-30
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-17 English Compare
v2 2020-01-17 French Compare
v3 2020-01-30 English Compare
v4 2020-01-30 French Compare